Directory
>
Glenn Whaley
Glenn Whaley
Chief Financial Officer | Immunic Therapeutics
Bloomingdale, New Jersey, United States
Glenn Whaley
Summary
Glenn Whaley is a seasoned financial executive with extensive experience in the pharmaceutical and biotechnology industries. Currently serving as the Chief Financial Officer at Immunic Therapeutics, he has a proven track record in financial management, strategic planning, and executive leadership. His expertise spans across accounting, financial analysis, mergers & acquisitions, and compliance with the Sarbanes-Oxley Act. Glenn has held various senior roles in notable companies, including Pernix Therapeutics and Alvogen, where he was instrumental in driving financial operations and strategic initiatives. A graduate of Rutgers University, he combines his academic background with over three decades of professional experience. His leadership style focuses on collaboration and transparency, fostering a culture of accountability within financial teams. Glenn is passionate about leveraging financial insights to support organizational growth and sustainability.
Glenn Whaley
Work Experience
Chief Financial Officer at
Immunic Therapeutics
March 2022 - Present
VP Finance Principal Financial and Accounting Officer at
Immunic Therapeutics
December 2019 - March 2022
VP Finance, Principal Accounting Officer and Controller at
Pernix Therapeutics
April 2015 - August 2019
VP Corporate Controller at
Alvogen
May 2011 - March 2015
AVP and Controller at
ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company
January 2005 - June 2011
Director of Financial Reporting at
KMC Telecom
September 1999 - December 2004
Manager of Mergers and Acquisitions at
Nokia
July 1998 - April 2000
Financial Reporting at
Pfizer
January 1994 - January 1997
Audit Senior at
KPMG
January 1991 - January 1994
Glenn Whaley
Education
Rutgers University, Bachelors
January 1970 - January 1970
Rutgers University–New Brunswick
Frequently Asked Questions about Glenn Whaley
What is Glenn Whaley email address?
Glenn Whaley's primary email address is ************@immunic-therapeutics.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Glenn Whaley work for?
Glenn Whaley is a Chief Financial Officer at Immunic Therapeutics, a company specializing in Commercial physical research.
Where Glenn Whaley graduated from?
Glenn Whaley holds a degree in Bachelor Of Science from Rutgers University.
How can I directly contact Glenn Whaley?
To contact Glenn Whaley directly, you can use the email address ************@immunic-therapeutics.com. Complete contact information is available upon registration with Muraena.
Who is Glenn Whaley?
Glenn Whaley is a seasoned financial executive with extensive experience in the pharmaceutical and biotechnology industries. Currently serving as the Chief Financial Officer at Immunic Therapeutics, he has a proven track record in financial management, strategic planning, and executive leadership. His expertise spans across accounting, financial analysis, mergers & acquisitions, and compliance with the Sarbanes-Oxley Act. Glenn has held various senior roles in notable companies, including Pernix Therapeutics and Alvogen, where he was instrumental in driving financial operations and strategic initiatives. A graduate of Rutgers University, he combines his academic background with over three decades of professional experience. His leadership style focuses on collaboration and transparency, fostering a culture of accountability within financial teams. Glenn is passionate about leveraging financial insights to support organizational growth and sustainability.
Glenn`s contact details
************@immunic-therapeutics.com
*******@imux.com
Colleagues
Chief Executive Officer
Executive Chairman
Vice President Investor Relations and Communications
Chief Development Officer (CDO)